Inactivated whole virion vaccine protects K18-hACE2 Tg mice against the Omicron SARS-CoV-2 variant via cross-reactive T cells and nonneutralizing antibody responses

Kruglov, AA; Bondareva, MA; Gogoleva, VS; Semin, IK; Astrakhantseva, IV; Zvartsev, R; Lunin, AS; Apolokhov, VD; Shustova, EY; Volok, VP; Ustyugov, AA; Ishmukhametov, AA; Nedospasov, SA; Kozlovskaya, LI; Drutskaya, MS

Kruglov, AA; Drutskaya, MS (通讯作者),Russian Acad Sci, Engelhardt Inst Mol Biol, Ctr Precis Genome Editing & Genet Technol Biomed, Moscow, Russia.;Kruglov, AA (通讯作者),German Rheumatism Res Ctr, Leibniz Inst, Dept Syst Rheumatol, Berlin, Germany.

EUROPEAN JOURNAL OF IMMUNOLOGY, 2023; ():

Abstract

COVID-19 is a systemic inflammatory disease initiated by SARS-CoV-2 virus infection. Multiple vaccines against the Wuhan variant of SARS-CoV-2 have be......

Full Text Link